Alloantibodies in Pediatric Heart Transplantation

Stopped early

Conditions studied: Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients

In brief

The purpose of this study is to determine the clinical outcomes of sensitized pediatric heart transplant recipients with a positive donor-specific cytotoxicity crossmatch and to compare this group with outcomes in nonsensitized heart transplant recipients.

Key facts

Study ID
NCT01005316
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
290
Starts
2010-01-01
Expected to finish
2014-12-01
Last updated by the study team
2017-04-20

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.